Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr-Jun;8(2):97-104.
doi: 10.4103/0974-8490.172659.

Characterization of Anticancer Principles of Celosia argentea (Amaranthaceae)

Affiliations

Characterization of Anticancer Principles of Celosia argentea (Amaranthaceae)

Rukhsana A Rub et al. Pharmacognosy Res. 2016 Apr-Jun.

Abstract

Background: An Indian origin, Celosia argentea is a weed growing during rainy season traditionally claimed for treating several ailments. Early researches on C. argentea were focused on the anti-cancer screening of seeds, with few reports on aerial parts.

Objective: To isolate and characterize bioactive compounds of aerial parts of C. argentea and evaluate their anticancer potential.

Materials and methods: The methanolic aerial part extract was fractionated on column chromatography using chloroform: methanol mixture. The fractions; 80:20 and 95:5 were purified on MCI-HP20 HPLC column. Chromatographically pure compounds were pooled, concentrated and characterized spectroscopically. The compounds were further screened for anti-oxidant and cytotoxic potential.

Results: Isolated compounds were confirmed as: (1) Luteolin-7-O-glucoside and (2) phenolic, 1-(4-hydroxy-2-methoxybenzofuran-5-yl)-3-phenylpropane-1,3-dione. Both exhibited significant antioxidant potential with IC50 values of 20.80 and 21.30 μg/ml for 2,2-diphenyl-1-picrylhydrazyl assay (***P < 0.001) and significant Trolox equivalent antioxidant capacity (TEAC) values for 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (*P < 0.05) and ferric reducing antioxidant potential assay (****P < 0.0001). In 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide assay, Compound 1 and 2 showed potent cytotoxicity against SiHa, HCT, MCF-7 cancer cell lines at 20 μg/ml (****P < 0.0001) and 18 μg/ml (**P < 0.01), respectively, without affecting the normal Vero cells. Both compounds enabled maximum reduction in cell viability at 50 μg/ml against HT-29 (***P < 0.001) and MCF-7 cell lines (**P < 0.01) in try pan blue viability assay. Apoptosis occurred at concentrations of 47.33 ± 0.8 μg/ml and 56.28 ± 1.2 μg/ml for Compound 1 and 35.15 ± 0.4 μg/ml and 28.05 ± 0.3 μg/ml for Compound 2 for HT-29 and MCF-7 respectively.

Conclusion: A novel anticancer phenolic compound; (1-(4-hydroxy-2-methoxybenzofuran-5-yl)-3-phenylpropane-1,3-dione), isolated from aerial parts of C. argentea was a valuable finding of the research.

Summary: The present study validated the potential of the plant C. argentea as an antioxidant, and anticancer remedy with two valuable isolations. Although one of them is a known compound: Luteolin 7-0 glycoside, the other isolated phenolic compound;-{1-(4-hydroxy-2-methoxybenzofuran-5-yl)-3-phenylpropane-1,3-dione}, is the first to be reported and thus can be considered as a valuable outcome of this research work.

Keywords: 2; 2-diphenyl-1-picrylhydrazylDPPH; 3(4; 5-dimethylthiazol-2-yl)-2; 5-diphenyl-tetrazoliumbromideMTT; Celosia argentea; anti-oxidant; anticancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Celosia argentea plant
Figure 2
Figure 2
Chromatogram showing Compound 1 on MCI HP 20 HPLC column
Figure 3
Figure 3
Chromatogram showing Compound 2 on MCI HP 20 HPLC column
Figure 4
Figure 4
Ultra violet Spectrum of compounds
Figure 5
Figure 5
Infrared Spectra of compounds
Figure 6
Figure 6
Proton nuclear magnetic resonance spectra of compounds
Figure 7
Figure 7
Mass spectra of compounds
Figure 8
Figure 8
HPTLC profile of compounds along with markers
Figure 9
Figure 9
Percentage inhibition of isolated Compound 1 and 2 for 2,2-diphenyl-1-picrylhydrazyl assay
Figure 10
Figure 10
IC50 values of isolated Compounds 1 and 2 for 2,2-Diphenyl-1-picrylhydrazyl Assay
Figure 11
Figure 11
Concentration response curve of Trolox for 2, 2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) at 734 nm
Figure 12
Figure 12
Percentage inhibition and TEAC values of isolated compounds for 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) assay
Figure 13
Figure 13
Absorbance, percentage inhibition and TEAC values for isolated compounds by ferric reducing antioxidant potential assay
Figure 14
Figure 14
3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide assay of isolated Compound 1
Figure 15
Figure 15
3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide assay of isolated Compound 2
Figure 16
Figure 16
Effect of Compound 1 and 2 on cell viability of HT-29
Figure 17
Figure 17
Figure 17: Effect of Compound 1 and 2 on cell viability of MCF-7
Figure 18
Figure 18
Cell morphology of apoptotic cells after test drugs treatment

References

    1. Orhue ER, Inneh S. Uptake of lead by Celosia argentea in an ultisol. Res J Agric Biol Sci. 2010;3:103–7.
    1. Ghule S, Prakash T, Kotresha D, Karki R, Surendra V, Goli D. Anti-diabetic activity of Celosia argentea root in steptozocin-induced diabetic rats. Int J Green Pharm. 2010;4:206–11.
    1. Morita H, Shimbo K, Shigemori H, Kobayashi J. Antimitotic activity of moroidin, a bicyclic peptide from the seeds of Celosia argentea. Bioorg Med Chem Lett. 2000;10:469–71. - PubMed
    1. Suzuki H, Morita H, Iwasaki S, Kobayashi J. New anti-mitotic bicyclic peptides, celogentins D, H, and J, from the seeds of Celosia argentea. Tetrahedron. 2003;59:5307–15.
    1. Hayakawa Y, Fujii H, Hase K, Ohnishi Y, Sakukawa R, Kadota S, et al. Anti-metastatic and immunomodulating properties of the water extract from Celosia argentea seeds. Biol Pharm Bull. 1998;21:1154–9. - PubMed

LinkOut - more resources